AMH Testing

Assessing ovarian reserve in a woman’s 30s with AMH testing

One of the fertility tests that our New York fertility center offers can help predict a woman’s reproductive potential should she choose to delay family building. Anti-Müllerian hormone, or AMH, is present in very immature follicles within a woman’s ovarian reserve. A blood test administered at any time during a woman’s cycle measures chemicals released by these primordial egg-bearing follicles.

A woman is born with all of the oocytes, or eggs, she will ever have. Each egg is contained in a sac-like follicle.

Granulosa cells that surround each egg in very young follicles secrete AMH, and blood levels of AMH relate directly to a woman’s remaining egg supply. While it can’t provide definitive answers, we consider this test an essential element in a full fertility workup, particularly for women of advanced maternal age (over 35), those with a history of failed IVF cycles or family history of premature ovarian failure.

AMH testing combined with FSH for big-picture fertility indicators

In addition to AMH testing as a standalone factor, we will incorporate FSH and inhibin tests to measure different indirect biochemical aspects of ovarian reserve. Dr. Joel Batzofin will incorporate a woman’s age into the results to arrive at an Egg Retrieval Score™.

You can also expect to have ultrasound tests to assess your antral follicle count, another indicator of the potential to become pregnant from IVF treatment.

Determining the right age for AMH testing

Egg supply is depleted with the passing of time. Women often wait too long to address their inability to conceive and miss their window for successful treatment with reproductive technologies.

Without an easily available test for assessing egg supply, women have had to make decisions about when to have children with little or no information about their personal risk of diminished ovarian reserve.

If you are under 35 and wish to delay pregnancy for personal reasons, consider scheduling fertility testing to assess ovarian reserve. Other reasons for evaluating your future fertility potential include:

  • A family history of premature ovarian failure
  • A personal history of autoimmune disease
  • Previous chemotherapy or pelvic surgeries
  • A history of failed IVF or unexplained infertility
  • Results from AMH testing may warrant proactive fertility treatment

Dr. Batzofin will review the results of AMH testing with you, and the significance of your serum anti-Müllerian hormone levels. There is overlap between high/low categories, and scientists disagree as to what constitutes a “normal” level, so we will offer conservative estimates of your remaining ovarian supply.

AMH testing is one piece of the puzzle, so don’t be overly concerned with one number. That said, less than .05-1 ng/ml will lead us to believe that time is of the essence if you wish to become pregnant. We will also advise you if you have elevated AMH levels that may indicate PCOS.

Having a full fertility workup prior to IVF will provide essential data to optimize your chances in a given cycle. Contact us at our New York fertility center to schedule fertility testing with Dr. Joel Batzofin.